Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David T Dunn

Showing results (21-30 of 77) with videos related to

Pageof 8
Sort By:
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 12, 2018
Next generation sequencing of HIV-1 protease in the PIVOT trial of protease inhibitor monotherapyDavid T Dunn, Wolfgang Stöhr, Alejandro Arenas-Pinto, et al.
The Journal of Infectious Diseases|September 17, 2011
Transmission network parameters estimated from HIV sequences for a nationwide epidemicAndrew J Leigh Brown, Samantha J Lycett, Lucy Weinert, et al.
Pharmacoeconomics|March 12, 2016
Cost Effectiveness of Protease Inhibitor Monotherapy Versus Standard Triple Therapy in the Long-Term Management of HIV Patients: Analysis Using Evidence from the PIVOT TrialLars Oddershede, Simon Walker, Wolfgang Stöhr, et al.
AIDS (London, England)|September 11, 2015
A phylotype-based analysis highlights the role of drug-naive HIV-positive individuals in the transmission of antiretroviral resistance in the UKRaphaël Mourad, François Chevennet, David T Dunn, et al.
Health Technology Assessment (Winchester, England)|March 18, 2016
The Protease Inhibitor Monotherapy Versus Ongoing Triple Therapy (PIVOT) trial: a randomised controlled trial of a protease inhibitor monotherapy strategy for long-term management of human immunodeficiency virus infectionNicholas I Paton, Wolfgang Stöhr, Lars Oddershede, et al.
Antiviral Therapy|November 13, 2004
HIV drug resistance testing: is the evidence really there?David T Dunn, Diana M Gibb, Abdel G Babiker, et al.
Sexually Transmitted Infections|March 29, 2019
Predictive factors for HIV infection among men who have sex with men and who are seeking PrEP: a secondary analysis of the PROUD trialEllen White, David T Dunn, Monica Desai, et al.
The Open AIDS Journal|June 21, 2012
Mean Corpuscular Volume as a Marker for Adherence to Zidovudine-Containing Therapy in HIV-Infected AdultsJoseph O Mugisha, Katherine Donegan, Sarah Fidler, et al.
Pharmacogenetics and Genomics|December 24, 2010
Adipogenic gene variants in patients with HIV-associated lipodystrophySudeep P Pushpakom, Andrew Owen, F Javier Vilar, et al.
The Journal of Infectious Diseases|October 13, 2016
No Evidence That HIV-1 Subtype C Infection Compromises the Efficacy of Tenofovir-Containing Regimens: Cohort Study in the United KingdomEllen White, Erasmus Smit, Duncan Churchill, et al.
Pageof 8

Showing results (21-30 of 77) with videos related to

Sort By:
Pageof 8
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 12, 2018
Next generation sequencing of HIV-1 protease in the PIVOT trial of protease inhibitor monotherapyDavid T Dunn, Wolfgang Stöhr, Alejandro Arenas-Pinto, et al.
The Journal of Infectious Diseases|September 17, 2011
Transmission network parameters estimated from HIV sequences for a nationwide epidemicAndrew J Leigh Brown, Samantha J Lycett, Lucy Weinert, et al.
Pharmacoeconomics|March 12, 2016
Cost Effectiveness of Protease Inhibitor Monotherapy Versus Standard Triple Therapy in the Long-Term Management of HIV Patients: Analysis Using Evidence from the PIVOT TrialLars Oddershede, Simon Walker, Wolfgang Stöhr, et al.
AIDS (London, England)|September 11, 2015
A phylotype-based analysis highlights the role of drug-naive HIV-positive individuals in the transmission of antiretroviral resistance in the UKRaphaël Mourad, François Chevennet, David T Dunn, et al.
Health Technology Assessment (Winchester, England)|March 18, 2016
The Protease Inhibitor Monotherapy Versus Ongoing Triple Therapy (PIVOT) trial: a randomised controlled trial of a protease inhibitor monotherapy strategy for long-term management of human immunodeficiency virus infectionNicholas I Paton, Wolfgang Stöhr, Lars Oddershede, et al.
Antiviral Therapy|November 13, 2004
HIV drug resistance testing: is the evidence really there?David T Dunn, Diana M Gibb, Abdel G Babiker, et al.
Sexually Transmitted Infections|March 29, 2019
Predictive factors for HIV infection among men who have sex with men and who are seeking PrEP: a secondary analysis of the PROUD trialEllen White, David T Dunn, Monica Desai, et al.
The Open AIDS Journal|June 21, 2012
Mean Corpuscular Volume as a Marker for Adherence to Zidovudine-Containing Therapy in HIV-Infected AdultsJoseph O Mugisha, Katherine Donegan, Sarah Fidler, et al.
Pharmacogenetics and Genomics|December 24, 2010
Adipogenic gene variants in patients with HIV-associated lipodystrophySudeep P Pushpakom, Andrew Owen, F Javier Vilar, et al.
The Journal of Infectious Diseases|October 13, 2016
No Evidence That HIV-1 Subtype C Infection Compromises the Efficacy of Tenofovir-Containing Regimens: Cohort Study in the United KingdomEllen White, Erasmus Smit, Duncan Churchill, et al.
Pageof 8